Susanne V. Schmidt studied biology at the University of Cologne. She graduated in 2009 investigating the modulation of dendritic cell function by tumor cells at the Institute for Virology in Cologne. In 2010 Susanne Schmidt joined as a PostDoc the Genomics & Immunoregulatory Group at the LIMES Institute in Bonn. Since 2017 Susanne is a member of the Eicke Latz Group. She is a certified clinical monitor and holds further educational certificates in the fields of Genomic Data Science, Machine Learning, Psychology, Positive Psychiatry and Mental Health. Her current research is focused on the decipherment of epigenetic and transcriptional programming of peripheral monocytes during SARS-CoV-2 infection, identification of biomarkers for patients at risk to develop hyperinflammatory immune reactions, monitoring of epigenetic alterations in brain tumors and the role of TAM receptors in the regulation of myeloid cell programming.
birding, playing piano, handwork, motorcycling, alternative rock
